̽»¨Ö±²¥

Scientists at AstraZeneca, a global biopharmaceutical company, have been working with Cambridge ̽»¨Ö±²¥Â for more than two decades. What are the secrets of their success?

Wren Therapeutics secures £18 million in funding to tackle protein misfolding diseases.